Analyst Ratings for Tarsus Pharmaceuticals (TARS)
TARS Rating Summary
TARS Price Target Summary
- Highest: $100.00 (Barclays)
- Lowest: $87.00 (Guggenheim)
- Average: $94.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$94.40 (+56.6%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$94.40 (+56.6%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | Oppenheimer » Updated 5/20/2026 |
Mazahir Alimohamed | New Coverage | Outperform (N/A) |
97.00 (98.00) |
60.97 (60.29) |
-1.12% | Details |
| 12/9/2025 | Barclays | Glen Santangelo | New Coverage | Overweight (N/A) |
100.00 (N/A) |
81.77 (60.29) |
-26.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
